Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel

BACKGROUND: Platelet P2Y12 antagonist ticagrelor reduces mortality after acute myocardial infarction (AMI) compared to clopidogrel, but the underlying mechanism is unknown. Because activated platelets, leukocytes, and endothelial cells release proinflammatory and prothrombotic extracellular vesicles...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasecka, Aleksandra, Nieuwland, Rienk, Budnik, Monika, Dignat‐George, Françoise, Eyileten, Ceren, Harrison, Paul, Lacroix, Romaric, Leroyer, Aurélie, Opolski, Grzegorz, Pluta, Kinga, van der Pol, Edwin, Postuła, Marek, Siljander, Pia, Siller‐Matula, Jolanta M., Filipiak, Krzysztof J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065161/
https://www.ncbi.nlm.nih.gov/pubmed/31833175
http://dx.doi.org/10.1111/jth.14689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065161/
https://www.ncbi.nlm.nih.gov/pubmed/31833175
http://dx.doi.org/10.1111/jth.14689

Ejemplares similares